Antibody Drug Conjugate (ADC)

In this case study, Frontage develops a multiplexed LC-MS/MS assay that generates multiple PK profiles from one single sample preparation, saving sample volume, significantly increasing the assay throughput, and reducing costs.

"*" indicates required fields

Comments

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Antibody Drug Conjugate (ADC)

Resources to Consider

Bioanalytical Strategies for PK Analysis of Antibody-Drug Conjugates...

WRIB 2025: Innovative Strategy for Overcoming pH-Related Assay...

Bioanalysis of antibody-drug conjugates (ADCs) by LC/MS: challenges...

Accurate determination of drug-to-antibody ratio of interchain...

Characterization of Positional Isomers of Interchain Cysteine Linked...

Simultaneous quantification of total antibody and antibody-conjugated...

Characterization of Interchain Cysteine Linked Antibody Drug...

Quantitative Analysis of Antibody Conjugate Payload by LC MS/MS...

Immunocapture-liquid Chromatography/Mass Spectrometry in Simultaneous...

Development of a Neutralizing Antibody Assay to support Clinical...

WRIB 2025: Integrated Non-cell Based and Cell-based NAb Assays for a...

Drug Metabolism and Pharmacokinetics (DMPK) Services